The Advanced Research Projects Agency for Health (ARPA-H) Partners with Palantir to Accelerate Health Outcomes By Leveraging AI/ML and Data Software Tooling
June 20 2024 - 6:59AM
Business Wire
Palantir Technologies Inc. (NYSE: PLTR) today announced that it
has been selected by the Advanced Research Projects Agency for
Health (ARPA-H) to support the agency’s mission to accelerate
better health outcomes. Palantir’s AIP and Foundry software will
help the agency drive key workflows by providing a data strategy
and infrastructure that will underpin business operations and
enable continuous improvement. The contract is worth $19 million
over 2 years.
The Advanced Research Projects Agency for Health (ARPA-H)
mission mandate is to accelerate better health outcomes for
everyone by supporting the development of high-impact solutions to
society's most challenging health problems. The agency advances
high-potential, high-impact biomedical and health research that
cannot be readily accomplished through traditional research or
commercial activity.
Investing in an enterprise data strategy provides the
organization with the continuous feedback loop to accelerate
innovation. Ultimately, this approach enables ARPA-H to track and
learn from outcomes to accomplish their bold goals—while remaining
accountable to the Government and the public.
"At ARPA-H, we are pioneering a data-centric approach to
transform business efficiency and accelerate program design. Our
focus is on data and harnessing the power of artificial
intelligence (AI) to rapidly develop new insights that not only
will streamline our operations, but also drive better outcomes for
all stakeholders involved in the ARPA-H mission. We strongly
believe that harnessing the power of data and AI is the key to
unlocking unprecedented levels of efficiency, productivity, and
overall success, while enabling us to focus on the research best
able to impact the lives of real people,” said Alastair Thomson,
Director of Data Innovation, ARPA-H.
To meet the ambitious goals laid out by the agency, ARPA-H has
partnered with Palantir to provide the data infrastructure for
ARPA-H’s core operations in order to rapidly collect, synthesize,
analyze, and make decisions from a range of data sources while
ensuring security and privacy controls meet and exceed the
mandatory standards. This approach will enable critical workflows
based on commercial best practices, including but not limited to:
program strategy, planning and oversight, financial and performance
management, and the ability to track and analyze return on
investment. Palantir’s platform ensures that ARPA-H programs are
operating within a consistent data strategy and the framework
determined by ARPA-H.
“ARPA-H is an incredible investment in the next generation of
life-changing healthcare outcomes. We are honored to provide our
software to support their mission and deliver the latest commercial
technology to transform their operations,” said Hirsh Jain, Head of
Public Health and Senior Vice President, Federal at Palantir.
This work builds on Palantir’s experience providing data
infrastructure and AI tools to support public health initiatives
including creating the secure collaborative research platform for
N3C; ongoing tooling for disease surveillance at HHS and CDC; and
increasing speed of drug review at the FDA.
About Palantir Technologies Inc.
Foundational software of tomorrow. Delivered today. Additional
information is available at https://www.palantir.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. These statements may relate to, but are not limited to,
Palantir’s expectations regarding the amount and the terms of the
contract and the expected benefits of our software platforms.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted or quantified.
Forward-looking statements are based on information available at
the time those statements are made and were based on current
expectations as well as the beliefs and assumptions of management
as of that time with respect to future events. These statements are
subject to risks and uncertainties, many of which involve factors
or circumstances that are beyond our control. These risks and
uncertainties include our ability to meet the unique needs of our
customer; the failure of our platforms to satisfy our customer or
perform as desired; the frequency or severity of any software and
implementation errors; our platforms’ reliability; and our
customer’s ability to modify or terminate the contract. Additional
information regarding these and other risks and uncertainties is
included in the filings we make with the Securities and Exchange
Commission from time to time. Except as required by law, we do not
undertake any obligation to publicly update or revise any
forward-looking statement, whether as a result of new information,
future developments, or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240620001188/en/
Morgan Gress media@palantir.com
Palantir Technologies (NYSE:PLTR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Palantir Technologies (NYSE:PLTR)
Historical Stock Chart
From Jul 2023 to Jul 2024